Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Post by Bigmac4000on Jul 17, 2023 6:47pm
171 Views
Post# 35545080

Another lost trial and 1.7 million gone

Another lost trial and 1.7 million goneAnother lost trial. No David you can't spin this as a victory. The company wanted 4 million and win 1.7 million.  To be exact it said "The Panel awarded Syneos Health US$1,707,830.52 in damages plus interest for certain unpaid invoices" 

Paying less is not a victory , it's a settlement. They picked a company that played them and wasted $1.7 million. 

One funny comment was the comment that FSD is looking for other bioscience companies that have been burned by Syneos in the past. I smell a class action in the works, why else would FSD be enquiring?  

Oh well, instead of bankrupt by November we are bankrupt by October. Sad state if affairs. 
I never even know about this trial. Did anyone else know in advance? Weird it wasn't readily available anywhere. Like the $53 million lawsuit for stolen proprietary information and 30+ million for wrongful dismissal, lost shares and court violations. 
<< Previous
Bullboard Posts
Next >>